A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)

BMC Nephrology

Loreto Gesualdo²  Mario Giordano³  Giuseppe Grandaliano¹  Vincenza Carbone³  Flora Puteo³  Sterpeta Diella¹  Giuseppe Stefano Netti¹  Maddalena Gigante¹  Luisa Santangelo³ 

[1] Center for Renal Immunopathology, Molecular Diagnostics and Regenerative Medicine, Bari-Foggia, Italy;Unit of Nephrology, Dialysis and Transplantation, Department of Emergency and Organ Transplantation - University “Aldo Moro”, Bari, Italy;Unit of Pediatric Nephrology, University Hospital “Policlinico Consorziale - Giovanni XXIII”, Bari, Italy

关键词: Mutational analysis;    SMARCAL1;    Schimke immuno-osseus dysplasia;    Focal segmental glomerulosclerosis;   

Others  :  1082718
DOI  :  10.1186/1471-2369-15-41

 received in 2013-09-11, accepted in 2014-02-25,  发布年份 2014

【 摘 要 】

Background

Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1.

Case presentation

We report the clinical and genetic diagnosis of a 5-years old girl with SIOD, referred to our Center because of nephrotic-range proteinuria occasionally detected during the follow-up for congenital hypothyroidism. Mutational analysis of SMARCAL1 gene was performed by polymerase chain reaction (PCR) and bidirectional sequencing. Sequence analysis revealed that patient was compound heterozygous for two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p.Glu848*).

Conclusion

This report provided the clinical and genetic description of a mild phenotype of Schimke immuno-osseous dysplasia associated with nephrotic proteinuria, decreasing after combined therapy with ACE inhibitors and sartans. Our experience highlighted the importance of detailed clinical evaluation, appropriate genetic counseling and molecular testing, to provide timely treatment and more accurate prognosis.

【 授权许可】

   
2014 Santangelo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Schimke RN, Horton WA, King CR: Chondroitin-6-sulphaturia, defective cellular immunity, and nephrotic syndrome. Lancet 1971, 2:1088-1089.
• [2]Spranger J, Hinkel GK, Stoss H, Thoenes W, Wargowski D, Zepp F: Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr 1991, 119:64-72.
• [3]Lücke T, Franke D, Clewing JM, Boerkoel CF, Ehrich JH, Das AM, Zivicnjak M: Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. Pediatrics 2006, 118:e400-e407.
• [4]Boerkoel CF, O’Neill S, André JL, Benke PJ, Bogdanovíć R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Fründ S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Ormälä T, Rener-Primec Z, Santava A, Santos HG, Schmidt B, Smith GC, Spranger J, Zupancic N, et al.: Manifestations and treatment of Schimke immuno- osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr 2000, 159:1-7.
• [5]Saraiva JM, Dinis A, Resende C, Faria E, Gomes C, Correia AJ, Gil J, da Fonseca N: Schimke immuno-osseous dysplasia: case report and review of 25 patients. J Med Genet 1999, 36:786-789.
• [6]Ehrich JH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J: Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol 1995, 43:89-95.
• [7]Coleman MA, Eisen JA, Mohrenweiser HW: Cloning and characterization of HARP/SMARCAL1: a prokaryotic HepArelated SNF2 helicase protein from human and mouse. Genomics 2000, 65:274-282.
• [8]Muthuswami R, Truman PA, Mesner LD, Hockensmith JW: A eukaryotic SWI2/SNF2 domain, an exquisite detector of double-stranded to single-stranded DNA transition elements. J Biol Chem 2000, 275:7648-7655.
• [9]Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, André JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Fründ S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, et al.: Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno osseous dysplasia. Nat Genet 2002, 30:215-220.
• [10]Clewing JM, Fryssira H, Goodman D, Smithson SF, Sloan EA, Lou S, Huang Y, Choi K, Lücke T, Alpay H, André JL, Asakura Y, Biebuyck-Gouge N, Bogdanovic R, Bonneau D, Cancrini C, Cochat P, Cockfield S, Collard L, Cordeiro I, Cormier-Daire V, Cransberg K, Cutka K, Deschenes G, Ehrich JH, Fründ S, Georgaki H, Guillen-Navarro E, Hinkelmann B, Kanariou M, et al.: Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat 2007, 28:273-83.
• [11]Hall MC, Matson SW: Helicase motifs: the engine that powers DNA unwinding. Mol Microbiol 1999, 34:867-877.
• [12]Gigante M, D’Altilia M, Montemurno E, Diella S, Bruno F, Netti GS, Ranieri E, Stallone G, Infante B, Grandaliano G, Gesualdo L: Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation. BMC Nephrol 2013, 14:60. BioMed Central Full Text
• [13]Sorting Intolerant From Tolerant (SIFT) programme web site http://sift.jcvi.org/www/SIFT_enst_submit.html webcite
• [14]Polyphen programme web site http://genetics.bwh.harvard.edu/pph2/ webcite
• [15]Bökenkamp A, de Jong M, van Wijk JA, Block D, van Hagen JM, Ludwig M: R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia. Pediatr Nephrol 2005, 20:1724-1728.
• [16]Zivicnjak M, Franke D, Zenker M, Hoyer J, Lücke T, Pape L, Ehrich JH: SMARCAL1 mutations: a cause of prepubertal idiopathic steroid-resistant nephritic syndrome. Pediatr Res 2009, 65(5):564-568.
• [17]Ghosal G, Yuan J, Chen J: The HARP domain dictates the annealing helicase activity of HARP/SMARCAL1. EMBO Rep. 2011, 12:574-80.
• [18]Ozdemir N, Alpay H, Bereket A, Bereket G, Biyikli N, Aydoğan M, Cakalağoğlu F, Kiliçaslan I, Akpinar I: Membranous nephropathy in Schimke immuno-osseous dysplasia. Pediatr Nephrol 2006, 21:870-872.